Topiramate 68462-0374
Product NDC
68462-0374- Manufacturer
- Glenmark Pharmaceuticals Inc., Usa
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 1, 2021
- Listing Expires
- December 31, 2027
- Application
- ANDA210278
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 100 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(3)
500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-374-05)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-374-30)
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-374-90)